Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nammex is a private Canadian functional mushroom ingredient company focused on certified organic mushroom powders and extracts for the health and wellness industry. Founded in 1989, the company supplies B2B raw materials to nutraceutical and supplement brands rather than developing prescription therapeutics. Its portfolio includes mushroom extracts such as Lion’s Mane, Cordyceps, Reishi, Chaga, Turkey Tail, Shiitake, Maitake, Tremella, Poria, Phellinus, and Oyster. Nammex emphasizes fruiting-body mushroom sourcing, organic cultivation partnerships in China, wholesale distribution in North America, and analytical quality control including chemical fingerprinting and species authentication. The business is best characterized as a commercial nutraceutical ingredients manufacturer and scientific quality leader in functional mushrooms rather than a clinical-stage biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nammex.